BioView and Transgenomic Enter into Distribution Agreement
News Nov 07, 2007
BioView Ltd. of Israel and Transgenomic, Inc. of Nebraska announced that they have entered into an agreement allowing Transgenomic to distribute BioView's family of Scanning and Analysis Workstations in selected Western European countries and Scandinavia.
Transgenomic's European sales and support organization will market, sell and service the instruments. BioView's products include the Duet, Allegro and Accord automated workstations for the scanning and classification of cells via fluorescence in-situ hybridization (FISH) and brightlight microscopy. The results of the scan are reviewed on the BioView Solo offline workstation for the final report.
The BioView products are intended for in-vitro diagnostic use as an aiding tool to the pathologist in the detection, classification and counting of cells of interest based on color, intensity, size, pattern, and shape.
The BioView products have applications for testing in hematological disorders, breast cancer studies for Her-2 neu gene amplification, bladder cancer screening and follow up using Vysis UroVysion™ Bladder Cancer Recurrence Kit and prenatal and postnatal genetic testing.
Dr. Opher Shapira, President and CEO of BioView Ltd., views this agreement as an opportunity for BioView to expand its market penetration in Europe in an efficient manner.
According to Shapira, "Transgenomic has a reputation amongst its European customer base for providing superior service and support. Following our success in the U.S. market, we believe that this agreement with Transgenomic will help establish us in a similar manner in the Western European and Scandinavian countries covered by this agreement."
Craig Tuttle, President and CEO of Transgenomic added, "We are very excited to add BioView's world-leading imaging platforms to our cytogenetics portfolio of products. These sophisticated imaging systems will complement our HANABI Metaphase Chromosome Harvester and spreader products and further expand our sales and service reach into cytogenetics and pathology laboratories across Europe."
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Mouse Model Demonstrates Potential of New Autism DrugNews
Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, largely corrected electrical, behavioral and brain abnormalities in the mice.READ MORE